Cantor Fitzgerald CEO Howard Lutnick was pitching ... today announced its results for the second quarter ended June 30, 2024. DUBLIN, Calif., July 29, 2024--AEye, Inc. (NASDAQ: LIDR), a global ...

But the ad hoc group of officials from Euronext Dublin, stockbroking, accountancy, PR and law firms that huddled together in ...

Ires Reit’s shares soared to their highest level in eight months after Taoiseach Micheál Martin signalled over the weekend that the rent cap system may be changed, or even removed, this year. The ...

Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable,” suggesting that there could be a shift in fund flows towards different ...

Division 1B has been blown wide open with Carlow beating promotion favourites Waterford last weekend while Antrim will be looking for a big boost under Davy Fitzgerald. Dublin did beat Antrim in ...

Cantor Fitzgerald raised concerns about the Magnificent Seven stocks, suggesting they may be at risk of losing investor interest as fund flows shift to other sectors. Revenue projections for 2025 are ...

Cantor Fitzgerald has a “Neutral” rating and a $110.00 price objective on the stock. The consensus estimate for Fortinet’s current full-year earnings is $2.05 per share. Get Fortinet alerts: ...

Cantor Fitzgerald currently has a “Overweight” rating and a $30.00 target price on the stock. The consensus estimate for AST SpaceMobile’s current full-year earnings is ($0.40) per share ...

Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed ...

Two Dublin southside pubs have been brought to the market this week by Lisney CRE. They are Fitzgerald’s Bar on Aston Quay in the city centre adjoining Dublin’s Temple Bar district, and Vaughan’s in ...

Wednesday, Western Digital Corp. (NASDAQ:WDC) shares maintained an Overweight rating by analysts at Cantor Fitzgerald, with a steady price target of $95.00. According to InvestingPro data ...

On Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...